There was a 30-fold surge in seizures of products asserting to be slendering and diabetic issues medicines in 2014.
The Health Products Regulatory Authority took 48,752 items providing as GLP‑1 products in 2025, compared to 1,582 in 2024.
Lots of were being marketed as declines or spots– in spite of the drugs not being lawfully readily available in those forms.
Common GLP-1 brand names include Ozempic, Mounjaro and Saxenda.
For much more on this tale and all the newest Irish and worldwide news – http://www.rte.ie/news
Many thanks for viewing and don’t neglect to subscribe.
#ireland #medicines #glp 1 #health